Original document(11 pages)  中文版
    A process for producing an imide compound hydrochloride. It is an excellent industrial process. The process, which is for producing either the imide compound hydrochloride represented by the formula (2): or enantiomers thereof, is characterized by treating either the compound represented by the formula (1): or enantiomers thereof with an aqueous hydrochloric acid solution in a hydrophilic medium and crystallizing the resultant hydrochloride.
Application Number
申请号
200480022168 Application Date
申请日
2004.07.27
Title 名称 Process for producing imide compound
Publication Number
公开号
1832946 Publication Date
公开日
2006.09.13
Approval Pub. Date Granted Pub. Date
International Classification 分类号 C07D417/12,A61K31/496,A61P25/28
Applicant(s) Name
申请人
Dainippon Sumitomo Pharma Co. Ltd.
Address 地址
Inventor(s) Name 发明人 Kakiya Yuzo
Attorney & Agent 代理人 guan lixin wang jingchao

  
Thiazole derivatives as npy antagonists
1- alkyl-1-azoniabicyclo (2.2.2) octane carbamate derivatives and their use as muscarinic receptor antagonists
Phosphoric acid salt of a dipeptidyl peptidase-iv inhibitor
Novel phosphonic acid compounds as inhibitors of serine proteases
Organophosphorus compound having phosphate-phosphonate bond, and flame-retardant polyester fiber and flame-retardant polyurethane resin composition each containing the same
Rare earth metal complex, material for thin-film formation, and process for producing thin film
Substituted ferrocenyldiphosphines as ligands for homogeneous hydrogenation catalysts
Production of 2'-deoxynucleosides and 2'-deoxynucleoside precursors from 2-dehydro-3-deoxy-d-gluconate
Isothermal amplification based assay for the detection and quantitation of alpha-fetoprotein mrna
Nucleic acid sequences encoding and compositions comprising ige signal peptide and/or il-15 and methods for using the same
Google
Note:All patent data come from State Intellectual Property Office of the People's Republic of China. If there were discrepancies between here and the State Intellectual Property office, the later is more accurate. The patent data is only for public exchange and learning purposes. We are not responsible for the adverse consequences with unverified use of the data.